HYSINGLA ER Drug Profile, 2020

$499.00

HYSINGLA ER Drug Profile, 2020

This report focuses on HYSINGLA ER and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources
SKU: 206627 Category:

Description

Copyright © DrugPatentWatch. Originally published at HYSINGLA ER Drug Profile, 2020

HYSINGLA ER Drug Profile, 2020

This report focuses on HYSINGLA ER and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

Contents

  • Profile for HYSINGLA ER
  • US Patents
  • Expired US Patents
  • Paragraph IV Patent Challenges
  • International (exUS) Patents
  • Drug Prices – Average Pharmacy Cost
  • Annual Sales Revenues
  • Finished Product Suppliers
  • Bulk API Sources

    Make Better Decisions with DrugPatentWatch

    Get the Daily Briefing or Try a trial

    Copyright © DrugPatentWatch. Originally published at HYSINGLA ER Drug Profile, 2020